The self-expanding A-Flux device is implanted in the coronary sinus to increase pressure on the venous side of the heart and improve perfusion in smaller vessels.

Eight reports of major bleeding have been reported from Impella introducers, prompting the FDA early alert this week. 

Leadless pacing in the Bachmann's bundle may be the next phase in the evolution of cardiac pacing technology.